Flore by Sun Genomics

About:

Sun Genomics provides personalized probiotic solutions based on AI and whole-genome sequencing of the microbiome.

Website: https://flore.com/

Twitter/X: sungenomics

Top Investors: IndieBio, SOSV, Human Longevity, Pangaea Ventures, Target Takeoff

Description:

Sun Genomics is a precision nutrition company focused on curing dysbiosis through the gut microflora and personalized solutions. Its flagship product Floré, is a microbiome test and custom synbiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product based on their unique gut profiles. The company also offers: Floré Tots, Kids, and Baby, available for kids up to age 0-12, and comes in an easy digestive powder to mix with their favorite drink. Floré Clinical, which is specifically for professional practitioners and their patients. Floré Defense, Balance, and Performance for sports teams and athletes.

Total Funding Amount:

$12.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2016-01-01

Contact Email:

customerservice(AT)sungenomics.com

Founders:

Sunny Jain

Number of Employees:

11-50

Last Funding Date:

2023-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai